Ngā hua rapu kaituhi

1

The clinical manifestations and management of COVID-19-related liver injury mā Tung‐Hung Su, Jia‐Horng Kao

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis mā Tung‐Hung Su, Jia‐Horng Kao, Chun‐Jen Liu

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Artificial intelligence in precision medicine in hepatology mā Tung‐Hung Su, Chih–Horng Wu, Jia‐Horng Kao

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective mā Tung‐Hung Su, Chih‐Horng Wu, Tsung‐Hao Liu, Cheng‐Maw Ho, Chun‐Jen Liu

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients mā Huei-Ru Cheng, Chun‐Jen Liu, Tai–Chung Tseng, Tung‐Hung Su, Hwai‐I Yang, Chien-Jen Chen, Jia‐Horng Kao

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters mā Tai–Chung Tseng, Chun‐Jen Liu, Tung‐Hung Su, Chia–Chi Wang, Chi‐Ling Chen, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection mā Chen‐Hua Liu, Chun‐Jen Liu, Tung‐Hung Su, Yu‐Jen Fang, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease mā Shang‐Chin Huang, Hau-Jyun Su, Jia‐Horng Kao, Tai–Chung Tseng, Hung‐Chih Yang, Tung‐Hung Su, Pei‐Jer Chen, Chun‐Jen Liu

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C mā Tung‐Hung Su, Chen‐Hua Liu, Chun‐Jen Liu, Chi‐Ling Chen, Te‐Tien Ting, Tai–Chung Tseng, Pei‐Jer Chen, Jia‐Horng Kao, Ding‐Shinn Chen

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping mā Chen‐Hua Liu, Cheng‐Chao Liang, Chun‐Jen Liu, Chih‐Lin Lin, Tung‐Hung Su, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection mā Yu‐Ping Chang, Chiuan-Bo Huang, Jia‐Horng Kao, Tung‐Hung Su, Shang‐Chin Huang, Tai–Chung Tseng, Pei‐Jer Chen, Chun‐Jen Liu, Chen‐Hua Liu

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters mā Tai–Chung Tseng, Chun‐Jen Liu, Chi‐Ling Chen, Chia‐Chi Wang, Tung‐Hung Su, Stephanie Fang‐Tzu Kuo, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice mā Wei‐Hsiang Lin, Shiou‐Hwei Yeh, Kun‐Huei Yeh, Kai-Wei Chen, Ya‐Wen Cheng, Tung‐Hung Su, Ping Jao, Lin-Chun Ni, Pei‐Jer Chen, Ding‐Shinn Chen

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy mā Tung‐Hung Su, Hung‐Chih Yang, Tai–Chung Tseng, Jyh‐Ming Liou, Chen‐Hua Liu, Chi‐Ling Chen, Pei‐Jer Chen, Ding‐Shinn Chen, Chun‐Jen Liu, Jia‐Horng Kao

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

$Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial$

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial mā Jeong Heo, Ja‐Der Liang, Chang Won Kim, Hyun Young Woo, I‐Lun Shih, Tung‐Hung Su, Zhong‐Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei‐Jer Chen

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images mā Yunhao Bai, Bokai Zhu, Xavier Rovira‐Clavé, Han Chen, Maxim Markovic, Chi Ngai Chan, Tung-Hung Su, David R. McIlwain, Jacob D. Estes, Leeat Keren, Garry P. Nolan, Sizun Jiang

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Hepatitis C viral infection increases the risk of lymphoid‐neoplasms: A population‐based cohort study mā Tung‐Hung Su, Chun‐Jen Liu, Tai–Chung Tseng, Shih‐Wan Chou, Chen‐Hua Liu, Hung‐Chih Yang, Shang‐Ju Wu, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Jia‐Horng Kao

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B mā Tung‐Hung Su, Ching‐Sheng Hsu, Chi‐Ling Chen, Chen‐Hua Liu, Yi‐Wen Huang, Tai–Chung Tseng, Chun‐Jen Liu, Pei‐Jer Chen, Ming‐Yang Lai, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load mā Tai–Chung Tseng, Chun‐Jen Liu, Hung‐Chih Yang, Tung‐Hung Su, Chia–Chi Wang, Chi‐Ling Chen, Stephanie Fang‐Tzu Kuo, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation mā Tai–Chung Tseng, Chun‐Jen Liu, Tung‐Hung Su, Hung‐Chih Yang, C.-C. Wang, C.-L. Chen, Stephanie Fang‐Tzu Kuo, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Tung-Hung Su

The clinical manifestations and management of COVID-19-related liver injury mā Tung‐Hung Su, Jia‐Horng Kao

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis mā Tung‐Hung Su, Jia‐Horng Kao, Chun‐Jen Liu

Artificial intelligence in precision medicine in hepatology mā Tung‐Hung Su, Chih–Horng Wu, Jia‐Horng Kao

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective mā Tung‐Hung Su, Chih‐Horng Wu, Tsung‐Hao Liu, Cheng‐Maw Ho, Chun‐Jen Liu

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients mā Huei-Ru Cheng, Chun‐Jen Liu, Tai–Chung Tseng, Tung‐Hung Su, Hwai‐I Yang, Chien-Jen Chen, Jia‐Horng Kao

Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters mā Tai–Chung Tseng, Chun‐Jen Liu, Tung‐Hung Su, Chia–Chi Wang, Chi‐Ling Chen, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection mā Chen‐Hua Liu, Chun‐Jen Liu, Tung‐Hung Su, Yu‐Jen Fang, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease mā Shang‐Chin Huang, Hau-Jyun Su, Jia‐Horng Kao, Tai–Chung Tseng, Hung‐Chih Yang, Tung‐Hung Su, Pei‐Jer Chen, Chun‐Jen Liu

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C mā Tung‐Hung Su, Chen‐Hua Liu, Chun‐Jen Liu, Chi‐Ling Chen, Te‐Tien Ting, Tai–Chung Tseng, Pei‐Jer Chen, Jia‐Horng Kao, Ding‐Shinn Chen

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping mā Chen‐Hua Liu, Cheng‐Chao Liang, Chun‐Jen Liu, Chih‐Lin Lin, Tung‐Hung Su, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection mā Yu‐Ping Chang, Chiuan-Bo Huang, Jia‐Horng Kao, Tung‐Hung Su, Shang‐Chin Huang, Tai–Chung Tseng, Pei‐Jer Chen, Chun‐Jen Liu, Chen‐Hua Liu

Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters mā Tai–Chung Tseng, Chun‐Jen Liu, Chi‐Ling Chen, Chia‐Chi Wang, Tung‐Hung Su, Stephanie Fang‐Tzu Kuo, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice mā Wei‐Hsiang Lin, Shiou‐Hwei Yeh, Kun‐Huei Yeh, Kai-Wei Chen, Ya‐Wen Cheng, Tung‐Hung Su, Ping Jao, Lin-Chun Ni, Pei‐Jer Chen, Ding‐Shinn Chen

Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy mā Tung‐Hung Su, Hung‐Chih Yang, Tai–Chung Tseng, Jyh‐Ming Liou, Chen‐Hua Liu, Chi‐Ling Chen, Pei‐Jer Chen, Ding‐Shinn Chen, Chun‐Jen Liu, Jia‐Horng Kao

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial mā Jeong Heo, Ja‐Der Liang, Chang Won Kim, Hyun Young Woo, I‐Lun Shih, Tung‐Hung Su, Zhong‐Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei‐Jer Chen

Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images mā Yunhao Bai, Bokai Zhu, Xavier Rovira‐Clavé, Han Chen, Maxim Markovic, Chi Ngai Chan, Tung-Hung Su, David R. McIlwain, Jacob D. Estes, Leeat Keren, Garry P. Nolan, Sizun Jiang

Hepatitis C viral infection increases the risk of lymphoid‐neoplasms: A population‐based cohort study mā Tung‐Hung Su, Chun‐Jen Liu, Tai–Chung Tseng, Shih‐Wan Chou, Chen‐Hua Liu, Hung‐Chih Yang, Shang‐Ju Wu, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Jia‐Horng Kao

Ngā utauta rapu:

Ngā marau whai pānga